This is part of heta-lang project.
This is Quantitative Systems Pharmacology (QSP) modeling platform describing Fatty Acid Amide Hydrolase inhibition in human.
- The human model of FAAH inhibition was developed by InSysBio and Pfizer in 2012 to support the analysis of clinical data on perspective pain killer PF‐04457845.
- The model was published in CPT: Pharmacokinetics & Systems Pharmacology journal in 2014.
- The SBML code of the model was published on BioModels Database in 2014 under CC0 license.
- In January 2016 it was model of the month of BioModels Database
- In 2019 the model was published on GitHub as QSP modeling platform in Heta notation.
- Evgeny Metelkin
- Natalia Bagrova
- Neil Benson
- Oleg Demin
- Piet van der Graaf
(c) InSysBio 2019-2021